Zhunan, Taiwan

Wun-Shaing Wayne Chang

This inventor holds 1 USPTO granted patent. Top assignees: Dcb-USA LLC, National Health Research Institutes, National Tsing Hua University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wun-Shaing Wayne Chang. Retrieved from https://idiyas.com/inventor/wun-shaing-wayne-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Wun-Shaing Wayne Chang

Introduction: Wun-Shaing Wayne Chang is a notable inventor based in Zhunan, Taiwan, recognized for his impactful work in the field of biochemistry. With a focus on developing therapeutics targeting critical health issues, he has made significant strides in the medical research community.

Latest Patents: Wun-Shaing Wayne Chang holds a patent for "Cathepsin S inhibitors," which includes inhibitors characterized by specific formulas as outlined in the patent specification. These inhibitors are particularly promising in the treatment of cancer and autoimmune/inflammatory diseases, showcasing the potential for innovative solutions in healing and wellness.

Career Highlights: Throughout his career, Wun-Shaing Wayne Chang has been associated with notable organizations including DCB-USA LLC and National Tsing Hua University. His experiences at these institutions have provided him with a robust platform to advance his research and innovate in the realm of biochemical therapies.

Collaborations: Chang has collaborated with distinguished coworkers such as Chun-Cheng Lin and Biing-Jiun Uang, further enriching his research endeavors. These collaborations have played a vital role in refining his inventions and expanding their applications in the healthcare industry.

Conclusion: Wun-Shaing Wayne Chang's contributions to the field of biochemistry and therapeutics exemplify the spirit of innovation that drives advancements in medicine. His patented Cathepsin S inhibitors represent a meaningful step forward in addressing some of the most pressing health challenges today. As he continues to collaborate and innovate, his work promises to have lasting impacts on the treatment of serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…